Development of new anti-epilepsy treatments targeting cellular energetics through mitochondrial modulation with optimal pharmacokinetics and toxicity profiles
Ended Project Grant Awarded Last action
- Award ID
- R44NS097047
- Recipient
-
Neuroene Therapeutics Inc. UEI FE9HTJ2TLGY5
- Awarding agency
-
National Institute of Neurological Disorders and Stroke
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,561,437
Award facts
- Assistance listing
- 93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders
- Completion date
- Originally
- Place of performance
- South Carolina, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | -$5 | |
| Amendment | -$5 | |
| Amendment | $61,530 | |
| Amendment | $749,959 | |
| Original award | $749,959 |
Quick answers
Who received award R44NS097047?
R44NS097047 was awarded to Neuroene Therapeutics Inc. by National Institute of Neurological Disorders and Stroke (National Institutes of Health) on July 1, 2016.
How much is award R44NS097047 worth?
$1,561,437 has been obligated on R44NS097047.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award